Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
14 studies found for:    Open Studies | "Respiratory Syncytial Virus Infections"
Show Display Options
Rank Status Study
1 Recruiting Viral Inhibition in Children for Treatment of RSV
Condition: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Interventions: Drug: AK0529;   Drug: Placebo
2 Recruiting Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: D46/NS2/N/ΔM2-2-HindIII;   Biological: Placebo
3 Recruiting Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV D46/NS2/N/ΔM2-2-HindIII Vaccine;   Biological: Placebo
4 Recruiting A Study to Evaluate Safety and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 17 Months
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV vaccine (GSK3389245A) low dose;   Biological: RSV vaccine (GSK3389245A) middle dose;   Biological: RSV vaccine (GSK3389245A) high dose;   Drug: Placebo LD;   Drug: Placebo MD;   Drug: Placebo HD
5 Recruiting A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897;   Drug: Placebo
6 Not yet recruiting RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA-BN-RSV;   Other: Placebo
7 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
8 Recruiting Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: D46cpΔM2-2 vaccine;   Biological: Placebo
9 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
10 Recruiting A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers
Conditions: Respiratory Syncytial Virus Infections;   Influenza, Human
Interventions: Biological: RSV A Memphis 37;   Biological: Influenza A/California/04/2009
11 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
12 Recruiting Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: Presatovir;   Drug: Placebo
13 Recruiting Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis
Conditions: Bronchiolitis;   Bronchiolitis, Viral;   RSV Infection;   Respiratory Failure
Intervention: Diagnostic Test: Nasal and Bronchial Sampling
14 Recruiting TGF-(Beta) and Susceptibility to RSV
Conditions: Respiratory Syncytial Virus;   Asthma
Intervention:

Study has passed its completion date and status has not been verified in more than two years.